Jakavi 15 contains Ruxolitinibe, 15mg, supplied as tablet. Manufacturer: Novartis India. Therapeutic class: JAK1/2 Inhibitor.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.